[1] She is a professor of medicine currently working in the Division of Infectious Disease at the University of Massachusetts Medical School.
[1] Following her Ph.D., she was postdoc at Trinity College Dublin until 2004 when she moved to the University of Massachusetts Medical School.
[4] Fitzgerald is known for her research in the field of innate immunity and the biology behind inflammatory responses in diseases.
[8] In 2021, Fitzgerald published results on an antiviral option to block replication in SARS-CoV-2, the viral agent responsible for COVID-19.
[9] In 2011, Fitzgerald was a finalist for the Vilcek Prize for Creative Promise in Biomedical Science.